LFSC
Exchange-traded product on NASDAQ (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Aug 31, 2026
The full portfolio as of the quarter end Aug 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Oct 30, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of May 31, 2026.
39 lines, 38 linked, weights sum to 100.04% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| Travere Therapeutics Inc | TVTX US89422G1076 | Equity | 165,892 | −4,822 | 8.71% | $ 10.995M |
| Corcept Therapeutics Inc | CORT US2183521028 | Equity | 74,897 | +2,443 | 6.72% | $ 8.49M |
| Spyre Therapeutics Inc | SYRE US00773J2024 | Equity | 94,677 | +3,089 | 6.70% | $ 8.457M |
| LivaNova PLC | LIVN GB00BYMT0J19 | Equity | 104,627 | +3,415 | 6.61% | $ 8.35M |
| Cogent Biosciences Inc | COGT US19240Q2012 | Equity | 233,781 | +7,639 | 6.48% | $ 8.182M |
| Mirum Pharmaceuticals Inc | MIRM US6047491013 | Equity | 55,641 | +4,730 | 4.32% | $ 5.456M |
| Billiontoone Inc | BLLN US0901681058 | Equity | 53,729 | +24,706 | 3.86% | $ 4.872M |
| Guardant Health Inc | GH US40131M1099 | Equity | 30,287 | −14,407 | 3.81% | $ 4.816M |
| Cytokinetics Inc | CYTK US23282W6057 | Equity | 62,243 | +18,975 | 3.50% | $ 4.414M |
| United Therapeutics Corp | UTHR US91307C1027 | Equity | 8,102 | +261 | 3.27% | $ 4.135M |
| Axsome Therapeutics Inc | AXSM US05464T1043 | Equity | 19,398 | +6,675 | 3.05% | $ 3.851M |
| Nektar Therapeutics | NKTR US6402683063 | Equity | 52,589 | +1,713 | 2.97% | $ 3.754M |
| TransMedics Group Inc | TMDX US89377M1099 | Equity | 43,305 | +1,411 | 2.91% | $ 3.675M |
| Savara Inc | SVRA US8051111016 | Equity | 673,019 | +21,995 | 2.87% | $ 3.628M |
| VeraDermics Inc | MANE US9229671048 | Equity | 36,765 | +1,197 | 2.87% | $ 3.618M |
| ICU Medical Inc | ICUI US44930G1076 | Equity | 20,198 | +3,971 | 2.77% | $ 3.493M |
| Dianthus Therapeutics Inc | DNTH US2528281080 | Equity | 32,291 | −2,593 | 2.70% | $ 3.41M |
| Trevi Therapeutics Inc | TRVI US89532M1018 | Equity | 196,667 | −34,935 | 2.59% | $ 3.265M |
| Viridian Therapeutics Inc | VRDN US92790C1045 | Equity | 137,759 | +4,498 | 2.53% | $ 3.19M |
| Palvella Therapeutics Inc | PVLA US6979471090 | Equity | 17,830 | +576 | 2.15% | $ 2.721M |
| Twist Bioscience Corp | TWST US90184D1000 | Equity | 18,448 | +598 | 2.03% | $ 2.564M |
| Corvus Pharmaceuticals Inc | CRVS US2210151005 | Equity | 170,887 | +5,582 | 1.90% | $ 2.399M |
| Ceribell Inc | CBLL US15678C1027 | Equity | 91,335 | +2,981 | 1.73% | $ 2.19M |
| Hinge Health Inc | HNGE US4333131039 | Equity | 18,179 | +589 | 1.33% | $ 1.683M |
| NeoGenomics Inc | NEO US64049M2098 | Equity | 85,594 | +42,523 | 1.21% | $ 1.533M |
| Waystar Holding Corp | WAY US9467841055 | Equity | 57,012 | +1,857 | 1.18% | $ 1.493M |
| Aveanna Healthcare Holdings In | AVAH US05356F1057 | Equity | 109,347 | +3,568 | 1.16% | $ 1.467M |
| Alphatec Holdings Inc | ATEC US02081G2012 | Equity | 149,732 | +72,346 | 1.11% | $ 1.403M |
| Globus Medical Inc | GMED US3795772082 | Equity | 16,802 | +544 | 1.08% | $ 1.367M |
| Praxis Precision Medicines Inc | PRAX US74006W2070 | Equity | 3,548 | new +3,548 | 0.98% | $ 1.243M |
| RadNet Inc | RDNT US7504911022 | Equity | 15,398 | +499 | 0.92% | $ 1.167M |
| Lumexa Imaging Holdings Inc | LMRI US5502491062 | Equity | 98,183 | +3,206 | 0.91% | $ 1.146M |
| Korro Bio Inc | KRRO US5009461089 | Equity | 64,974 | +2,119 | 0.64% | $ 811.525K |
| Wave Life Sciences Inc | WVE US94352A1043 | Equity | 157,141 | +5,133 | 0.61% | $ 769.991K |
| Insmed Inc | INSM US4576693075 | Equity | 6,248 | +198 | 0.60% | $ 761.131K |
| Replimune Group Inc | REPL US76029N1063 | Equity | 45,400 | new +45,400 | 0.55% | $ 694.62K |
| F/m Ultrashort Treasury Inflat | RBIL US74933W2136 | Fund | 11,287 | −11,464 | 0.45% | $ 564.011K |
| Alamar Biosciences Inc | ALMR US0109111056 | Equity | 9,757 | +315 | 0.24% | $ 297.979K |
|
U.S. Bank Money Market Deposit Account
|
USBFS04 8AMMF0A92 | Money market | 571.8 | +368.89 | 0.00% | $ 571.80 |
ETFs holding LFSC
Exchange-traded funds whose newest published daily portfolio holds this listing.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| NMBL | 2.58% | 13,677 | $ 597.554K | Nov 17, 2026 |